These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 6954300)

  • 21. Definition of the high-risk acute lymphoblastic leukemia patient by immunological phenotyping with monoclonal antibodies.
    Zipf TF; Fox RI; Dilley J; Levy R
    Cancer Res; 1981 Nov; 41(11 Pt 2):4786-9. PubMed ID: 6975160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in the cytologic characteristics of antibody-dependent cellular cytotoxicity of normal and leukemic bovine blood lymphocytes.
    Adomaitiene D; Dediniene J
    Anal Quant Cytol; 1981 Jun; 3(2):143-8. PubMed ID: 7258857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acute lymphoblastic leukemia of T-precursor cell--special reference to surface marker (author's transl)].
    Kawashima K; Kato Y; Ogura M; Suzuki H; Watanabe E; Takamatsu J; Minami S; Isobe K; Nagura E; Yamada K; Iwamura H; Yamamura M; Yokomaku S
    Rinsho Ketsueki; 1981 Jul; 22(7):1102-8. PubMed ID: 6977046
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cerebrospinal fluid immunoglobulins in children with lymphoblastic leukemia].
    Kubiczek K; Cyklis R; Włodek B; Amborska H
    Pediatr Pol; 1981 Sep; 56(9):1053-8. PubMed ID: 6948269
    [No Abstract]   [Full Text] [Related]  

  • 25. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia.
    Greaves MF
    Cancer Res; 1981 Nov; 41(11 Pt 2):4752-66. PubMed ID: 7028250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Surface markers of T and B lymphocytes: II. Their investigation in 13 patients with untreated acute lymphoblastic leukaemia (ALL) (author's transl)].
    Tomić BL
    Lijec Vjesn; 1980 Dec; 102(12):689-93. PubMed ID: 7022076
    [No Abstract]   [Full Text] [Related]  

  • 27. Cell surface markers in acute lymphoblastic leukemia.
    Humphrey GB; Blackstock R; Filler J
    Ann Clin Lab Sci; 1980; 10(3):169-80. PubMed ID: 6967278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prolymphocytoid transformation of chronic lymphoid leukemia].
    Juhász E; Telek B
    Orv Hetil; 1981 Aug; 122(33):2029-31. PubMed ID: 7312339
    [No Abstract]   [Full Text] [Related]  

  • 29. Lymphocyte markers in childhood ALL: the lack of correlation with prognosis.
    Cristo Morón E; Révész T; Schuler D
    Acta Paediatr Acad Sci Hung; 1982; 23(2):171-7. PubMed ID: 6982589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunological evaluation of 22 patients with acute lymphoblastic leukemia off-therapy. A longitudinal follow-up.
    Pasino M; Vadalà CR; De Bernardi B; Comelli A; Mori PG; Dini G; Bisogni MC; Tonini GP; Massimo L
    Helv Paediatr Acta; 1981 Feb; 36(1):69-80. PubMed ID: 6971861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Markers of cellular differentiation in acute lymphoblastic leukemia.
    Peiper SC; Stass SA
    Arch Pathol Lab Med; 1982 Jan; 106(1):3-8. PubMed ID: 6976157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Classification and prognosis of acute lymphoblastic leukemia.
    Bloomfield CD
    Prog Clin Biol Res; 1981; 58():167-83. PubMed ID: 7022480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunotherapy of acute leukemia with cells of cultured lymphoblast-like lines].
    Makhonova LA; Skorikova AS; Maiakova SA; Bulycheva TI; Ol'shanskaia NV
    Probl Gematol Pereliv Krovi; 1982 Sep; 27(9):15-20. PubMed ID: 6960345
    [No Abstract]   [Full Text] [Related]  

  • 34. B cell markers in Ph1-positive acute lymphoblastic leukemia.
    Alimena G; De Rossi G; Gastaldi R; Guglielmi C; Mandelli F
    Nouv Rev Fr Hematol (1978); 1980; 22(3):275-80. PubMed ID: 6970921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
    Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
    Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prognostic value of pre-B immunophenotype in early treatment response among acute pediatric lymphoblast leukemia patients].
    Correa-González LC; Mandeville PB; Manrique-Dueñas J; Alejo-González F; Salazar-Martínez A; de Pérez-Ramírez OJ; Hernández-Sierra JF
    Gac Med Mex; 2005; 141(6):477-82. PubMed ID: 16381501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunocytological and cytochemical classification of acute lymphoid leukemia in children].
    Lenskaia RV; Samochatova EV; Izotova TA; Baĭdun LV; Sokolov PP
    Sov Med; 1980; (10):26-33. PubMed ID: 6969445
    [No Abstract]   [Full Text] [Related]  

  • 38. Ex vivo expansion of highly purified NK cells for immunotherapy after haploidentical stem cell transplantation in children.
    Koehl U; Esser R; Zimmermann S; Tonn T; Kotchetkov R; Bartling T; Sörensen J; Grüttner HP; Bader P; Seifried E; Martin H; Lang P; Passweg JR; Klingebiel T; Schwabe D
    Klin Padiatr; 2005; 217(6):345-50. PubMed ID: 16307421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody affinity may influence antigenic modulation of the common acute lymphoblastic leukemia antigen in vitro.
    Lebien TW; Boué DR; Bradley JG; Kersey JH
    J Immunol; 1982 Nov; 129(5):2287-92. PubMed ID: 6956632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cytochemical characteristics and immunologic markers in acute lymphoblastic leukemias (author's transl)].
    Dorlhiac P; Genter G; Jamra M
    Sangre (Barc); 1981; 26(4):433-8. PubMed ID: 6974901
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.